10-Q: Mitesco Faces Going Concern Doubt Amid Q3 Losses
Quarterly Report
Mitesco, Inc. reported a significant net loss in Q3 2025 and faces substantial doubt about its ability to continue as a going concern, despite new ventures in data centers and AI.
Summary
- Mitesco, Inc. reported a net loss of $3,202,971 for the three months ended September 30, 2025, a significant decline from a net income of $2,077,028 in the prior year period.
- For the nine months ended September 30, 2025, net income decreased to $159,981 from $1,711,107 in the comparable period of 2024.
- Revenue for the three months ended September 30, 2025, was $3,000, down from $23,500 in the prior year, attributed to shifting resources to new software projects.
- Nine-month revenue increased to $38,700 from $29,500, primarily from the new Centcore, LLC data center services.
- Operating expenses surged to $1,014,422 for the three months and $1,668,862 for the nine months ended September 30, 2025, largely due to establishing new subsidiaries and software development, including $812,149 in stock-based compensation for Q3 2025.
- Cash and cash equivalents stood at a critically low $321 as of September 30, 2025, down from $3,402 at December 31, 2024.
- Total current liabilities were $17,583,270, and total liabilities were $23,950,712 as of September 30, 2025.
- The company has substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows from operations, and the need for additional funding.
- A debt restructuring in FY2024 converted over $25 million of obligations into restricted common stock and Series A Preferred Stock.
- The company is developing an AI-based application called 'Robo Agent' for residential real estate sales, expected Q4 FY2025, and secured a contract for a sports/pickleball arena application, expected late FY2025.
Sentiment
Score: 2
Explanation: The company faces severe financial distress, including a going concern doubt, critically low cash, significant losses, and substantial liabilities. While new business ventures are underway, their revenue generation is minimal, and the company remains highly dependent on further capital raises, which often come with dilutive terms. The identified material weaknesses in internal controls further compound the negative sentiment.
Positives
- Net cash used in operating activities improved for the nine months ended September 30, 2025, to $308,963, compared to $399,775 in the prior year.
- Total liabilities decreased from $26,605,787 at December 31, 2024, to $23,950,712 at September 30, 2025, primarily due to debt restructuring and settlements.
- The company successfully extinguished all FY2024 bridge notes through conversion into Series A Preferred shares.
- New business units, Centcore, LLC (data center services) and Vero Technology Ventures, LLC (cloud computing/AI), have been formed and are generating some revenue.
- Development of the 'Robo Agent' AI application and a new sports/pickleball arena application are underway, with an executive and contract programmers hired to accelerate development.
Negatives
- The company reported a significant net loss of $3,202,971 for the three months ended September 30, 2025, a substantial deterioration from a net income in the prior year.
- Cash and cash equivalents are critically low at $321 as of September 30, 2025, indicating severe liquidity issues.
- Revenue from data center services decreased significantly in Q3 2025 ($3,000 vs. $23,500), as resources were shifted to software development.
- Operating expenses increased substantially due to the establishment of new subsidiaries and software development, including high stock-based compensation.
- The company has a large accumulated deficit of $(63,695,370) as of September 30, 2025.
- Interest expense increased significantly to $1,137,355 for the nine months ended September 30, 2025, primarily due to Series A preferred shares accretion and interest on legal settlements.
- A loss on legal settlement of $500,000 was recorded in Q3 2025, and a loss on revaluation of Series A Preferred shares of $387,638 was also recorded.
- The Kishon Note was in default status at September 30, 2025, with principal and interest totaling $431,666 and $224,939, respectively, due.
Risks
- Substantial doubt exists about the company's ability to continue as a going concern for one year due to recurring losses, negative cash flows from operations, and the need to secure additional funding.
- The company's continuance is dependent on raising capital and generating sufficient revenues, for which no formal agreement exists as of the filing date.
- Significant changes in the company's ownership may limit the future use of its existing net operating loss carryforwards (approximately $63.1 million Federal and $17.7 million State).
- Material weaknesses in disclosure controls and procedures were identified, including a lack of segregation of duties and insufficient resources for timely SEC reporting.
- The company is subject to significant risks and uncertainties related to its new business plan, including the successful development and market acceptance of its AI-based applications and data center services.
- The Series A Preferred Stock has mandatory redemption features requiring repayment in cash or common stock, which could further dilute shareholders or strain cash resources.
- The company faces ongoing legal proceedings and obligations related to the winding down of its former clinic business activities, with total settlement obligations of $3,322,834 as of September 30, 2025.
Future Outlook
The company is actively developing new AI-based applications, including 'Robo Agent' for residential real estate sales, expected to be available for initial users in Q4 FY2025. A new application for the sports and pickleball arena is also expected to be completed in late FY2025. The company anticipates continuing its strategy of using consultants to control costs rather than building a large internal employment force. Its ability to continue operations is dependent on raising additional capital and generating sufficient revenues.
Management Comments
- "We shifted much of our limited resources to our new software projects during Q3 and as a result we saw a reduction in data center revenue."
- "The increase [in operating expenses] is the result of the Companys focus on establishing the operations of its newly formed subsidiaries as well as development of a software platform..."
- "Our Companys recurring losses from operations and negative cash flows from operations and our need to raise additional funding to finance our operations raise substantial doubt about our ability to continue as a going concern."
- "It is anticipated that this approach [using consultants] will continue indefinitely as it does not desire to create the overhead associated with a large employment force."
Industry Context
Mitesco is undergoing a significant strategic pivot, moving away from its failed primary care healthcare clinic operations towards high-growth technology sectors: data center services, cloud computing, and artificial intelligence. This aligns with broader industry trends emphasizing digital transformation and AI integration. However, the company is in a very early stage of these new ventures, operating with minimal cash and substantial legacy liabilities, which places it at a significant disadvantage compared to established players in these capital-intensive and competitive industries.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Newly elected director | During the nine months ended September 30, 2025 | Issued 2,400 shares of Series X Preferred Stock for compensation in lieu of services. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weaknesses | Identified material weaknesses in disclosure controls and procedures, including lack of segregation of duties and insufficient resources for timely SEC reporting. | As of September 30, 2025 | Adversely affects the company's ability to record, process, summarize, and report financial information accurately and timely. The company intends to take corrective action. |
Legal Proceedings
- Total legal settlement obligations related to the winding down of clinic business activities amount to $3,322,834 as of September 30, 2025.
- A Summary Judgment was granted on December 4, 2023, for the Egan Clinic (Vikings) for $488,491, with a total settlement obligation of $577,222 including interest.
- A stipulation for Judgment was filed on December 21, 2023, for the St. Paul Clinic (The Grove) for $415,266, with a total settlement obligation of $485,860 including interest.
- A Confession of Judgment was executed on April 2, 2024, for the St. Louis Park Clinic (Excelsior & Grand) for $425,350, with a total settlement obligation of $483,151 including interest.
- A settlement agreement was entered on October 22, 2022, for the Maple Grove Clinic (Arbor Lakes) for $219,576, with a total settlement obligation of $284,580 including interest.
- Amounts owed for the Radiant Clinic (LMC Welton) were settled for approximately $530,000 as of April 10, 2024.
- A Final Judgment was granted on November 14, 2023, for the Quincy Clinic (1776 Curtis) for $348,764. An additional judgment of $500,000 was provided on August 8, 2025, to settle a modification action, bringing the total settlement obligation to $936,463 including interest.
- The company is currently in negotiations for amounts owed for the Eden Prairie Clinic (TP Elevate) and believes no further obligations exist for the Nordhaus Clinic and administrative office leases.
Related Party Transactions
- Acquired the source code and business activities of AgingTopic, LLC on December 6, 2024, for a $5,000 cash payment and royalty payments up to $150,000, followed by a 2.5% commission. AgingTopic is controlled by Ms. Amy Lance, wife of Mack Leath (CEO).
- Lindstrom Note 1 and Lindstrom Note 2 were issued to Jenny Lindstrom, former Chief Legal Officer. These notes, along with accrued interest, were settled on April 24, 2025, by issuing 75,000 shares of restricted common stock.
- Issued 2,400 shares of Series X Preferred Stock to a newly elected director for compensation in lieu of services ($60,000 value) during the nine months ended September 30, 2025.
- Issued 20,000 shares of Series X Preferred Stock to an institutional investor and consultant for compensation in lieu of services ($500,000 value) during the nine months ended September 30, 2025.
Stakeholder Impact
- **Shareholders**: Significant dilution has occurred and is likely to continue due to ongoing capital raises and debt conversions into common stock. The substantial doubt about going concern and recurring losses pose a high risk to shareholder value.
- **Creditors**: The company has undertaken significant debt restructuring and legal settlements to address past obligations, but some notes remain in default, and new secured convertible notes have been issued, indicating ongoing risk.
- **Employees/Consultants**: The company relies heavily on consultants rather than a large employee base, which may offer flexibility but could impact long-term stability and talent retention if not managed effectively.
- **Customers (Centcore/VTV)**: The company's financial instability and going concern doubt could raise concerns about its ability to reliably provide long-term data center and software services, potentially impacting customer acquisition and retention.
Next Steps
- Continue development of the 'Robo Agent' AI application, with initial users expected in Q4 FY2025.
- Complete the new application for the sports and pickleball arena in late FY2025.
- Secure additional funding to sustain operations and execute the business plan.
- Address material weaknesses in disclosure controls and procedures, including lack of segregation of duties and insufficient resources for timely SEC reporting.
- Continue negotiations to settle remaining obligations related to former clinic operations.
Key Dates
| Date | Description |
|---|---|
| 2020-11-01 | Entered agreement to open Nordhaus Clinic in Minneapolis, Minnesota. |
| 2021-05-24 | Entered agreement to open St. Louis Park Clinic (Excelsior & Grand) in Minnesota. |
| 2021-06-08 | Entered agreement to open Eden Prairie Clinic (TP Elevate) in Minnesota. |
| 2021-06-24 | Entered agreement to open an administrative office in St. Louis Park, Minnesota. |
| 2021-08-31 | Entered agreement to open St. Paul Clinic (The Grove) in Minnesota. |
| 2021-09-09 | Entered agreement to open Radiant Clinic (LMC Welton) in Denver, Colorado. |
| 2021-09-28 | Entered agreement to open Quincy Clinic (1776 Curtis) in Denver, Colorado. |
| 2021-10-08 | Entered agreement to open Maple Grove Clinic (Arbor Lakes) in Minnesota. |
| 2021-10-14 | Entered agreement to open Egan Clinic (Vikings) in Minnesota. |
| 2022-05-10 | Entered Securities Purchase Agreement with Kishon Investments, LLC for a promissory note and warrants. |
| 2022-05-23 | Issued Finnegan Note 1 to Jessica Finnegan. |
| 2022-05-26 | Issued Finnegan Note 2 to Jessica Finnegan and Lindstrom Note 1 to Jenny Lindstrom. |
| 2022-08-04 | Issued Finnegan Note 3 to the Finnegans. |
| 2022-10-22 | Entered settlement agreement with leaseholder for Maple Grove Clinic for $219,576. |
| 2022-11-11 | Kishon Note entered default status. |
| 2022-11-21 | Finnegan Note 1 entered default status. |
| 2022-11-29 | Issued Lindstrom Note 2 to Jenny Lindstrom. |
| 2022-12-01 | Finnegan Note 2 and Lindstrom Note 1 entered default status. |
| 2023-07-12 | Received confirmation of payment plan arrangement from SBA for PPP loan. |
| 2023-11-06 | Received termination notice from landlord for Nordhaus Clinic lease. |
| 2023-11-14 | Final Judgment granted for Quincy Clinic in the amount of $348,764. |
| 2023-12-04 | Summary Judgment granted for Egan Clinic in the amount of $488,491. |
| 2023-12-15 | Entry of final judgment for Egan Clinic. |
| 2023-12-21 | Stipulation for Judgment filed for St. Paul Clinic in the amount of $415,266. |
| 2024-01-19 | Final entry of judgment by the Court for St. Paul Clinic. |
| 2024-04-02 | Agreed to and executed a Confession of Judgment for St. Louis Park Clinic in the amount of $425,350. |
| 2024-04-10 | Received fully executed and recorded judgment for St. Louis Park Clinic; settled amounts owed for Radiant Clinic for approximately $530,000. |
| 2024-06-01 | Announced the formation of Centcore, LLC and Vero Technology Ventures, LLC. |
| 2024-10-28 | Filed Certificate of Designation for Series A Preferred Stock with the Nevada Secretary of State. |
| 2024-12-06 | Closed on the acquisition of AgingTopic, LLC. |
| 2024-12-31 | Effective date for conversion of $580,132 of 2024 Bridge Notes into Series A Preferred shares. |
| 2025-01-01 | Series A Preferred Stock redemptions began monthly. |
| 2025-01-01 | Adopted ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. |
| 2025-04-24 | Entered Obligation Exchange Agreement with Finnegan and Lindstrom to settle notes and other obligations. |
| 2025-05-06 | Entered short term note payable agreement with an investor for $25,000 cash proceeds. |
| 2025-05-19 | Entered Senior Secured 5% Original Issue Discount Promissory Notes with three institutional investors for $75,000 gross proceeds. |
| 2025-07-21 | Entered Senior Secured 5% Original Issue Discount Promissory Notes with two institutional investors for $100,000 gross proceeds. |
| 2025-08-01 | Retained executive to begin development of Robo Agent product set. |
| 2025-08-08 | Settled Quincy Clinic legal matter by providing an additional judgment of $500,000. |
| 2025-09-01 | Received contract for development of a new application related to sports and pickleball arena. |
| 2025-09-30 | End of the reporting period for this Form 10-Q. |
| 2025-10-31 | Entered Senior Secured 10% Original Issue Discount Convertible Promissory Note (2025 Bridge Note) financing agreement for potential $1 million, with initial net proceeds of $250,000. |
| 2025-11-13 | Date of filing of this Form 10-Q and date of common stock outstanding count. |
Recommendation
strong sellMitesco, Inc. presents an extremely high-risk investment profile. The company explicitly states 'substantial doubt about our ability to continue as a going concern,' which is the most critical red flag for any investor. Its cash position is critically low ($321 at quarter-end, $55,000 post-financing), while liabilities remain substantial. Despite efforts to pivot into data centers and AI, these new ventures are nascent, generating minimal revenue, and the company continues to incur significant operating losses. The reliance on highly dilutive convertible debt for financing, coupled with identified material weaknesses in internal controls and ongoing legal obligations from past failed ventures, indicates severe operational and financial instability. The risk of total capital loss is exceptionally high, making it an unsuitable investment for all but the most speculative, risk-tolerant investors.
Keywords
Mitesco, 10-Q, Quarterly Report, Going Concern, Net Loss, Data Center Services, Cloud Computing, Artificial Intelligence, AI, Robo Agent, SEC Filing, Financial Reporting, Liquidity, Debt Restructuring, Preferred Stock, Legal Settlements, Internal Controls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.